Literature DB >> 24579735

Aging, nutrient signaling, hematopoietic senescence, and cancer.

Priya Balasubramanian1, Valter D Longo2.   

Abstract

It is well known that cancer is one of the main causes of mortality in the aged population. Recent studies suggest that oncogenic pathways, such as the insulin-like growth factor-1 (IGF-I), Ras, and Akt/PKB, can contribute to both aging and cancer not only by promoting growth and preventing apoptosis, but also by promoting DNA damage and genomic instability. Epidemiological studies suggest that the chronic, low-grade inflammation that accompanies aging also contributes to tissue damage and tumor progression. Coupled with the accumulation of senescent cells and declining immune function, this leads to the generation and survival of cancer cells, possibly explaining why advanced age is the primary risk factor for cancer.

Entities:  

Mesh:

Year:  2013        PMID: 24579735      PMCID: PMC3959897          DOI: 10.1615/critrevoncog.2013010596

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  132 in total

1.  IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function.

Authors:  L Ding; E M Shevach
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

2.  Numbers and functions of transplantable primitive immunohematopoietic stem cells. Effects of age.

Authors:  D E Harrison; C M Astle; M Stone
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

Review 3.  Extending healthy life span--from yeast to humans.

Authors:  Luigi Fontana; Linda Partridge; Valter D Longo
Journal:  Science       Date:  2010-04-16       Impact factor: 47.728

4.  Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer.

Authors:  John R Webb; Darin A Wick; Julie S Nielsen; Eric Tran; Katy Milne; Elissa McMurtrie; Brad H Nelson
Journal:  Gynecol Oncol       Date:  2010-06-11       Impact factor: 5.482

Review 5.  Aging, immunity, and cancer.

Authors:  Tamas Fulop; Anis Larbi; Rami Kotb; Flavia de Angelis; Graham Pawelec
Journal:  Discov Med       Date:  2011-06       Impact factor: 2.970

6.  A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis.

Authors:  Andrea Alimonti; Caterina Nardella; Zhenbang Chen; John G Clohessy; Arkaitz Carracedo; Lloyd C Trotman; Ke Cheng; Shohreh Varmeh; Sara C Kozma; George Thomas; Erika Rosivatz; Rudiger Woscholski; Francesco Cognetti; Howard I Scher; Pier Paolo Pandolfi
Journal:  J Clin Invest       Date:  2010-02-08       Impact factor: 14.808

7.  Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans.

Authors:  Jaime Guevara-Aguirre; Priya Balasubramanian; Marco Guevara-Aguirre; Min Wei; Federica Madia; Chia-Wei Cheng; David Hwang; Alejandro Martin-Montalvo; Jannette Saavedra; Sue Ingles; Rafael de Cabo; Pinchas Cohen; Valter D Longo
Journal:  Sci Transl Med       Date:  2011-02-16       Impact factor: 17.956

Review 8.  Gerontology as oncology. Research on aging as the key to the understanding of cancer.

Authors:  R A Miller
Journal:  Cancer       Date:  1991-12-01       Impact factor: 6.860

9.  Mechanisms of hematopoietic stem cell aging.

Authors:  Aysegul V Ergen; Margaret A Goodell
Journal:  Exp Gerontol       Date:  2009-12-23       Impact factor: 4.032

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.